Jushi Holdings (JUSHF) Current Leases (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Current Leases came in at $10.9 million in Q1 2026, up 11.63% year-on-year from $9.8 million in Q1 2025, and down 2.13% on a QoQ basis from $11.1 million in Q4 2025.
Jushi Holdings (JUSHF) Current Leases (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Current Leases data on file, last reported at $10.9 million in Q1 2026.
- On a quarterly basis, Current Leases rose 11.63% year-over-year to $10.9 million in Q1 2026; TTM through Mar 2026 was $10.9 million, a 11.63% increase from a year earlier, with the FY2025 full-year figure at $11.1 million, up 15.97% from the prior year.
- Current Leases for Q1 2026 stood at $10.9 million, down from $11.1 million in the prior quarter.
- Over the last five years, Current Leases for JUSHF reached as high as $13.1 million in Q2 2022 and fell as low as $8.7 million in Q3 2023.
- Historically, Current Leases has averaged $10.2 million across 5 years, with a median of $9.9 million in 2025.
- Across the five-year window, Current Leases plunged 33.02% in 2023 and climbed 15.97% in 2025, its largest moves.
- Year by year, Current Leases stood at $11.4 million in 2022, then dropped by 21.79% to $8.9 million in 2023, then grew by 7.97% to $9.6 million in 2024, then increased by 15.97% to $11.1 million in 2025, then dropped by 2.13% to $10.9 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $10.9 million in Q1 2026, $11.1 million in Q4 2025, and $10.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 10.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.89 Mn |
| Dec 31, 2025 | 11.13 Mn |
| Sep 30, 2025 | 10.29 Mn |
| Jun 30, 2025 | 10.03 Mn |
| Mar 31, 2025 | 9.75 Mn |
| Dec 31, 2024 | 9.59 Mn |
| Sep 30, 2024 | 9.31 Mn |
| Jun 30, 2024 | 8.96 Mn |
| Mar 31, 2024 | 9.12 Mn |
| Dec 31, 2023 | 8.89 Mn |
| Sep 30, 2023 | 8.74 Mn |
| Jun 30, 2023 | 8.79 Mn |
| Mar 31, 2023 | 10.29 Mn |
| Dec 31, 2022 | 11.36 Mn |
| Sep 30, 2022 | 12.74 Mn |
| Jun 30, 2022 | 13.12 Mn |
| Dec 31, 2021 | 12.62 Mn |